We next determined the in vivo anti-leukemia efficacy of adavosertib and panobinostat in the OCI-AML3 xenograft model as well as in AML PDX (patient-derived xenograft) models expressing mtNPM1 and FLT3-ITD in NSG mice. Here, FLT3 is linked to leukemia.